CD79A and COVID-19: Consistent with published data [27], the COVID-19 mRNA vaccine (Moderna and Pfizer) elicited the production of spike-specific IgA, showing similar patterns of induction and the time to reach peak levels than spike-specific IgG, but a more rapid decline in serum levels following both the first and second doses of the vaccine [27].